1t5q: Difference between revisions
From Proteopedia
Jump to navigationJump to search
New page: left|200px<br /> <applet load="1t5q" size="450" color="white" frame="true" align="right" spinBox="true" caption="1t5q" /> '''Solution Structure of GIP(1-30)amide in TFE... |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:1t5q.gif|left|200px]]<br /> | [[Image:1t5q.gif|left|200px]]<br /><applet load="1t5q" size="350" color="white" frame="true" align="right" spinBox="true" | ||
<applet load="1t5q" size=" | |||
caption="1t5q" /> | caption="1t5q" /> | ||
'''Solution Structure of GIP(1-30)amide in TFE/Water'''<br /> | '''Solution Structure of GIP(1-30)amide in TFE/Water'''<br /> | ||
==Overview== | ==Overview== | ||
Glucose-dependent insulinotropic polypeptide is an incretin hormone that | Glucose-dependent insulinotropic polypeptide is an incretin hormone that stimulates insulin secretion and reduces postprandial glycaemic excursions. The glucose-dependent action of GIP on pancreatic beta-cells has attracted attention towards its exploitation as a potential drug for type 2 diabetes. Use of NMR or X-ray crystallography is vital to determine the three-dimensional structure of the peptide. Therefore, to understand the basic structural requirements for the biological activity of GIP, the solution structure of the major biologically active fragment, GIP(1-30)amide, was investigated by proton NMR spectroscopy and molecular modelling. The structure is characterised by a full length alpha-helical conformation between residues F(6) and A(28). This structural information could play an important role in the design of therapeutic agents based upon GIP receptor agonists. | ||
==Disease== | ==Disease== | ||
| Line 11: | Line 10: | ||
==About this Structure== | ==About this Structure== | ||
1T5Q is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/ ]. Full crystallographic information is available from [http:// | 1T5Q is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/ ]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1T5Q OCA]. | ||
==Reference== | ==Reference== | ||
| Line 17: | Line 16: | ||
[[Category: Single protein]] | [[Category: Single protein]] | ||
[[Category: Alana, I.]] | [[Category: Alana, I.]] | ||
[[Category: Gault, V | [[Category: Gault, V A.]] | ||
[[Category: Harte, F | [[Category: Harte, F P.M O.]] | ||
[[Category: Hewage, C | [[Category: Hewage, C M.]] | ||
[[Category: Malthouse, J | [[Category: Malthouse, J P.G.]] | ||
[[Category: Parker, J | [[Category: Parker, J C.]] | ||
[[Category: diabetes]] | [[Category: diabetes]] | ||
[[Category: gip]] | [[Category: gip]] | ||
| Line 29: | Line 28: | ||
[[Category: obesity]] | [[Category: obesity]] | ||
''Page seeded by [http:// | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 15:10:10 2008'' | ||